newsfilter
← Latest News
GlobeNewswire·

Apollomics Announces Presentations of Vebreltinib Data at ESMO 2023

FOSTER CITY, Calif., Oct. 16, 2023 (GLOBE NEWSWIRE) -- Apollomics Inc. (NASDAQ:APLM) (the "Company"), a late-stage clinical biopharmaceutical company developing multiple oncology drug candidates to address